Literature DB >> 17434919

Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illness.

Amy F T Arnsten1.   

Abstract

Both dopamine (DA) and norepinephrine (NE) have powerful, inverted U influences on prefrontal cortical (PFC) cognitive function. Optimal NE levels engage alpha2A-adrenoceptors and increase "signals" via inhibition of cAMP-HCN (cAMP-hyperpolarization-activated cyclic nucleotide-gated cation channel) signaling near preferred inputs, whereas optimal levels of DA D1 receptor stimulation decrease "noise" by increasing cAMP signaling near nonpreferred inputs. Excessive levels of catecholamine release during stress impair working memory 1) by very high levels of cAMP-HCN signaling diminishing preferred as well as nonpreferred inputs and 2) by high levels of NE engaging alpha1 stimulation of phosphotidyl inositol (PI) signaling that suppresses cell firing. Common mental illnesses are associated with extracellular changes in these pathways: Attention Deficit Hyperactivity Disorder is linked to genetic changes that reduce catecholamine transmission to suboptimal levels and is treated with agents that increase catecholamine transmission, whereas Post-Traumatic Stress Disorder (PTSD) is associated with amplified noradrenergic transmission that impairs PFC but strengthens amygdala function. PTSD is now treated with agents that block alpha1 or beta adrenoceptors. In contrast, the more severe mental illnesses, schizophrenia and bipolar disorder, are associated with genetic changes in molecules regulating intracellular signaling pathways activated by stress. Specifically, DISC1 inhibits cAMP signaling whereas regulator of G-protein signaling 4 inhibits PI signaling. Loss of function in these genes may render patients vulnerable to profound stress-induced PFC dysfunction including symptoms of thought disorder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434919     DOI: 10.1093/cercor/bhm033

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  89 in total

Review 1.  Psychospiritual Resiliency: Enhancing Mental Health and Ecclesiastical Collaboration in Caring for Those Experiencing Dissociative Phenomena.

Authors:  Christopher J Howard
Journal:  J Relig Health       Date:  2017-02

Review 2.  Switching to hypomania and mania: differential neurochemical, neuropsychological, and pharmacologic triggers and their mechanisms.

Authors:  Jun Chen; Yiru Fang; David E Kemp; Joseph R Calabrese; Keming Gao
Journal:  Curr Psychiatry Rep       Date:  2010-12       Impact factor: 5.285

Review 3.  Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder.

Authors:  Craig W Berridge; David M Devilbiss
Journal:  Biol Psychiatry       Date:  2010-09-26       Impact factor: 13.382

4.  L-dopa modulates functional connectivity in striatal cognitive and motor networks: a double-blind placebo-controlled study.

Authors:  Clare Kelly; Greig de Zubicaray; Adriana Di Martino; David A Copland; Philip T Reiss; Donald F Klein; F Xavier Castellanos; Michael P Milham; Katie McMahon
Journal:  J Neurosci       Date:  2009-06-03       Impact factor: 6.167

5.  Changes in Endogenous Dopamine Induced by Methylphenidate Predict Functional Connectivity in Nonhuman Primates.

Authors:  Rasmus M Birn; Alexander K Converse; Abigail Z Rajala; Andrew L Alexander; Walter F Block; Alan B McMillan; Bradley T Christian; Caitlynn N Filla; Dhanabalan Murali; Samuel A Hurley; Rick L Jenison; Luis C Populin
Journal:  J Neurosci       Date:  2018-12-10       Impact factor: 6.167

6.  Toward a new understanding of attention-deficit hyperactivity disorder: advances in research and treatment.

Authors:  Thomas J Spencer
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

7.  Functional interplay between NMDA receptors, SK channels and voltage-gated Ca2+ channels regulates synaptic excitability in the medial prefrontal cortex.

Authors:  E S L Faber
Journal:  J Physiol       Date:  2010-03-01       Impact factor: 5.182

Review 8.  HCN Channel Targets for Novel Antidepressant Treatment.

Authors:  Stacy M Ku; Ming-Hu Han
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

Review 9.  The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortex.

Authors:  Robert C Spencer; David M Devilbiss; Craig W Berridge
Journal:  Biol Psychiatry       Date:  2014-09-28       Impact factor: 13.382

Review 10.  Does the concept of "sensitization" provide a plausible mechanism for the putative link between the environment and schizophrenia?

Authors:  Dina Collip; Inez Myin-Germeys; Jim Van Os
Journal:  Schizophr Bull       Date:  2008-01-18       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.